Style | Citing Format |
---|---|
MLA | M Soudmandi MAHDI, et al.. "Evaluation of the Prevalence of Hypomagnesemia and the Related Risk Factors in Patients Admitted to a Referral Heart Hospital in Isfahan." Advanced Biomedical Research, vol. 14, no. 1, 2025, pp. -. |
APA | M Soudmandi MAHDI, M Dianatkhah MEHRNOUSH, M Momenzadeh MAHNAZ, Z Teimourijervekani ZAHRA (2025). Evaluation of the Prevalence of Hypomagnesemia and the Related Risk Factors in Patients Admitted to a Referral Heart Hospital in Isfahan. Advanced Biomedical Research, 14(1), -. |
Chicago | M Soudmandi MAHDI, M Dianatkhah MEHRNOUSH, M Momenzadeh MAHNAZ, Z Teimourijervekani ZAHRA. "Evaluation of the Prevalence of Hypomagnesemia and the Related Risk Factors in Patients Admitted to a Referral Heart Hospital in Isfahan." Advanced Biomedical Research 14, no. 1 (2025): -. |
Harvard | M Soudmandi MAHDI et al. (2025) 'Evaluation of the Prevalence of Hypomagnesemia and the Related Risk Factors in Patients Admitted to a Referral Heart Hospital in Isfahan', Advanced Biomedical Research, 14(1), pp. -. |
Vancouver | M Soudmandi MAHDI, M Dianatkhah MEHRNOUSH, M Momenzadeh MAHNAZ, Z Teimourijervekani ZAHRA. Evaluation of the Prevalence of Hypomagnesemia and the Related Risk Factors in Patients Admitted to a Referral Heart Hospital in Isfahan. Advanced Biomedical Research. 2025;14(1):-. |
BibTex | @article{ author = {M Soudmandi MAHDI and M Dianatkhah MEHRNOUSH and M Momenzadeh MAHNAZ and Z Teimourijervekani ZAHRA}, title = {Evaluation of the Prevalence of Hypomagnesemia and the Related Risk Factors in Patients Admitted to a Referral Heart Hospital in Isfahan}, journal = {Advanced Biomedical Research}, volume = {14}, number = {1}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - M Soudmandi MAHDI AU - M Dianatkhah MEHRNOUSH AU - M Momenzadeh MAHNAZ AU - Z Teimourijervekani ZAHRA TI - Evaluation of the Prevalence of Hypomagnesemia and the Related Risk Factors in Patients Admitted to a Referral Heart Hospital in Isfahan JO - Advanced Biomedical Research VL - 14 IS - 1 SP - EP - PY - 2025 ER - |